BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Zhu B, Wang S, Wu Y, Zhan W, Xie S, Shi H, Yu R. Regulation of glioma migration and invasion via modification of Rap2a activity by the ubiquitin ligase Nedd4-1. Oncol Rep 2017;37:2565-74. [PMID: 28405688 DOI: 10.3892/or.2017.5572] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Jayaprakash S, Hegde M, BharathwajChetty B, Girisa S, Alqahtani MS, Abbas M, Sethi G, Kunnumakkara AB. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. Int J Mol Sci 2022;23:12380. [PMID: 36293239 DOI: 10.3390/ijms232012380] [Reference Citation Analysis]
2 Cao L, Liu X, Zheng B, Xing C, Liu J. Role of K63-linked ubiquitination in cancer. Cell Death Discov 2022;8:410. [PMID: 36202787 DOI: 10.1038/s41420-022-01204-0] [Reference Citation Analysis]
3 Li K, Niu Y, Yuan Y, Qiu J, Shi Y, Zhong C, Qiu Z, Li K, Lin Z, Huang Z, Zhang C, Zuo D, He W, Yuan Y, Li B. Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling. Oncogene. [DOI: 10.1038/s41388-022-02334-6] [Reference Citation Analysis]
4 Duncan ED, Han KJ, Trout MA, Prekeris R. Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. J Cell Biol 2022;221:e202107114. [PMID: 35293963 DOI: 10.1083/jcb.202107114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Conway JA, Kinsman G, Kramer ER. The Role of NEDD4 E3 Ubiquitin–Protein Ligases in Parkinson’s Disease. Genes 2022;13:513. [DOI: 10.3390/genes13030513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Rimkus TK, Arrigo AB, Zhu D, Carpenter RL, Sirkisoon S, Doheny D, Regua AT, Wong GL, Manore S, Wagner C, Lin H, Jin G, Ruiz J, Chan M, Debinski W, Lo H. NEDD4 degrades TUSC2 to promote glioblastoma progression. Cancer Letters 2022. [DOI: 10.1016/j.canlet.2022.01.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Duncan ED, Han K, Trout MA, Prekeris R. Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration.. [DOI: 10.1101/2021.12.06.471477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Li N, Shi H, Hou P, Gao L, Shi Y, Mi W, Zhang G, Wang N, Dai W, Wei L, Jin T, Shi Y, Guo S. ARRDC3 polymorphisms may affect the risk of glioma in Chinese Han. Funct Integr Genomics 2021. [PMID: 34748117 DOI: 10.1007/s10142-021-00807-7] [Reference Citation Analysis]
9 Kumari S, Arora M, Singh J, Kadian LK, Yadav R, Chauhan SS, Chopra A. Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:677979. [PMID: 34235179 DOI: 10.3389/fmolb.2021.677979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yang JR, Ling XL, Guan QL. RAP2A promotes apoptosis resistance of hepatocellular carcinoma cells via the mTOR pathway. Clin Exp Med 2021. [PMID: 34018090 DOI: 10.1007/s10238-021-00723-x] [Reference Citation Analysis]
11 Dutta D, Sharma V, Mutsuddi M, Mukherjee A. Regulation of Notch signaling by E3 ubiquitin ligases. FEBS J 2021. [PMID: 33644958 DOI: 10.1111/febs.15792] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Ren GF, Xiao LL, Ma XJ, Yan YS, Jiao PF. Metformin Decreases Insulin Resistance in Type 1 Diabetes Through Regulating p53 and RAP2A in vitro and in vivo. Drug Des Devel Ther 2020;14:2381-92. [PMID: 32606605 DOI: 10.2147/DDDT.S249557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang ZW, Hu X, Ye M, Lin M, Chu M, Shen X. NEDD4 E3 ligase: Functions and mechanism in human cancer. Semin Cancer Biol 2020;67:92-101. [PMID: 32171886 DOI: 10.1016/j.semcancer.2020.03.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
14 Sheykhzadeh S, Luo M, Peng B, White J, Abdalla Y, Tang T, Mäkilä E, Voelcker NH, Tong WY. Transferrin-targeted porous silicon nanoparticles reduce glioblastoma cell migration across tight extracellular space. Sci Rep 2020;10:2320. [PMID: 32047170 DOI: 10.1038/s41598-020-59146-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
15 Zhang J, Wei Y, Min J, Wang Y, Yin L, Cao G, Shen H. Knockdown of RAP2A gene expression suppresses cisplatin resistance in gastric cancer cells. Oncol Lett 2020;19:350-8. [PMID: 31897147 DOI: 10.3892/ol.2019.11086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
16 Song YH, Zhang CQ, Chen FF, Lin XY. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma. Chin Med J (Engl) 2018;131:16-24. [PMID: 29271375 DOI: 10.4103/0366-6999.221262] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Carvalho BC, Oliveira LC, Rocha CD, Fernandes HB, Oliveira IM, Leão FB, Valverde TM, Rego IMG, Ghosh S, Silva AM. Both knock-down and overexpression of Rap2a small GTPase in macrophages result in impairment of NF-κB activity and inflammatory gene expression. Mol Immunol 2019;109:27-37. [PMID: 30851634 DOI: 10.1016/j.molimm.2019.02.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Joshi V, Upadhyay A, Amanullah A, Mishra R, Mishra A. Predicting E3 Ubiquitin Ligases as Possible Promising Biomarkers for Brain Tumors. Molecular Diagnostics in Cancer Patients 2019. [DOI: 10.1007/978-981-13-5877-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]